tiprankstipranks
Innate Pharma (IPHA)
NASDAQ:IPHA
US Market
IPHA
Innate Pharma
RESEARCH TOOLSreports
Want to see IPHA full AI Analyst Report?

Innate Pharma (IPHA) Cash flow

132 Followers

Innate Pharma Cash Flow

IPHA's free cash flow for Q4 2025 was €-23.48M. For the 2025 fiscal year, IPHA's free cash flow was decreased by €-43.52M and operating cash flow was €-23.40M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
€ -50.67M€ -6.90M€ -32.56M€ -19.15M€ -58.46M
Investing Cash Flow
€ 7.00M€ 9.20M€ 20.63M€ 1.88M€ -917.00K
Financing Cash Flow
€ 5.83M€ -6.01M€ -1.97M€ -1.83M€ 26.82M
End Cash Position
€ 28.08M€ 66.40M€ 70.61M€ 84.22M€ 103.76M
Free Cash Flow
€ -50.81M€ -7.29M€ -34.91M€ -20.28M€ -59.79M
Currency in EUR

Innate Pharma Cash Flow